A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
Clinical trial NCT03573297 · COMPLETED
Trial details
- NCT number
- NCT03573297
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2022-09-05
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.